Roche · 4 weeks ago
Director, Cell Engineering, Cell Therapy
South San Francisco
Full-time
Onsite
Director/Executive
$182K/yr - $338K/yr
10+ years expRoche is committed to innovating for a healthier future, and they are seeking a Director of Cell Engineering in Cell Therapy. This role involves overseeing cell engineering technology development and managing a team of Principal Scientists to advance cell therapy products.
BiotechnologyHealth CareHealth DiagnosticsOncologyPharmaceuticalPrecision Medicine
Responsibilities
Build, develop and guide innovative technical and scientific talent in achieving its department objectives, including overseeing research programs executed through high quality laboratory research
Foster a culture of innovation, collaboration, and continuous improvement; set team goals, manage performance, and facilitate professional development
Collaborate within Cell Therapy and across the Company (Research, CMC, Genentech, and Roche Subsidiaries) to ensure collective leadership and seamless partnership in support of cell therapy discovery and development
Develop and implement the overall strategic plan(s) for innovative engineering approaches to engineer intrinsic cell properties using advanced genomic/epigenomic methods
Identify novel strategies for safe and efficient multiplex editing strategies that achieve technical design criteria without adversely compromising cell viability and safety
Integrate metabolic engineering strategies into existing spectrum of genomic/epigenomic editing platforms to further enable modulation of critical cellular properties for enhanced functional potency
Ability to lead and contribute productively to various types of genotoxicity assays that require development to fulfill safety and regulatory requirements
Qualification
Required
Ph.D. in a relevant scientific field such as cell biology, molecular biology, immunology, or bioengineering with a minimum of 3 years of Postdoctoral experience
Extensive knowledge of cell engineering strategies and implementation in primary (e.g. T cells) and pluripotent stem cells
Understanding of different editing tools, associated benefits and caveats to efficiently achieve complex engineered cell profiles
A minimum of 10 years of hands-on experience (can include Ph.D. work & Postdoctoral Fellowship) in a relevant field, of which at least 5 years of industry experience is preferred
A minimum of 8 years of progressively increasing level of responsibility in people leadership, in direct and matrixed organizations
Capable of guiding cross-functional teams while effectively communicating complex scientific data and strategy to diverse audiences, from lab scientists to executive management
Reputation and credibility as an emerging leader in the field, evidenced by a strong publication record or validated contributions in advancing Science
Demonstrated track record as an effective inclusive leader
Excellent communication skills (written and oral)
Benefits
Relocation benefits are available for this job posting.
A discretionary annual bonus may be available based on individual and Company performance.
Company
Roche
Roche is a pharmaceutical and diagnostics company that offers medicines and diagnostic tests for various medical conditions and diseases.
10001+ employees
H1B Sponsorship
Roche has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (12)
2024 (9)
2023 (6)
2022 (2)
2021 (2)
Funding
Current Stage
Public CompanyTotal Funding
$7.79BKey Investors
SoftBankSCALE AINovartis
2021-08-04Post Ipo Equity· $5B
2020-12-07IPO
2020-05-06Post Ipo Equity· $0.5M
Leadership Team
Alan Hippe
Member of the Executive Board - Group CFO
Christine Bakan
Global Head and VP of Software and Bioinformatics, Next Generation Sequencing
Recent News
Pharmaceutical Technology
2026-01-13
2026-01-12
Company data provided by crunchbase